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ABSTRACT
Objective: Multidrug-resistant strains are developed day by day due to empirical therapy in intensive care unit (ICU). Both Gram-positive and Gram-
negative strains are found in ICU are drug resistant bacteria. In this study, the prevalence of drug resistance bacteria in ICU were determined.
Methods: The clinical samples, ascitic fluid, blood, central line tip, ET aspiration pleural fluid, pus from liver abscess, sputum, tracheal aspiration, 
urine, and wound swabs were collected from ICU patients and cultured in specific medium. Subsequently, antibiotic sensitivity pattern of isolated 
bacteria was carried out with disc diffusion methods.
Results: A total number of 794 clinical samples were cultured in specific medium, and it revealed 191 of single colonies, 145 were double colonies 
and 87 were 3 or Multy-colonies. A total of 963 bacteria were isolated among them 180 were Gram-positive bacteria, budding yeast-like colony were 
135 and rest were Gram-negative bacteria. There was no significant difference in growth of microorganisms with respect to clinical samples as t-test 
revealed p=0.87. Among the Gram-negative bacteria; Klebsiela pneumonia were predominant, and Proteous mirabilis was lowest. Tigecycline and 
colistin were most effective antibiotics agonist all bacteria.
Conclusion: Urine samples of the patient’s revealed a higher number of organisms whereas pus from liver abscess found only one number of growths. 
The antibiotic stewardship programs must lead to significant decrease in all antibiotic used in the ICU setting. However, this result may be required 
further work to determine the fruitful necessary for success.
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INTRODUCTION
Antibiotic resistance is the most severe threats to public health today [1]. 
It is well documented that misuse of antibiotics contributes to develop 
of multidrug resistance strains and studies have shown that up to 50% 
of antibiotics use in clinical practice are inappropriate [2,3]. Antibiotic 
stewardship programs (ASPs) are highly being advised as key strategy to 
increase the suitability of antibiotic prescribing, with the aim of avoiding 
the emergence of resistance [1,3]. Some more advantage of appropriate 
antibiotic use results the reduction in adverse, including intensive care 
unit (ICU) infection and drug reactions, as well as a decrease in health-
care costs [4,5]. The World Health Organization (WHO), the Centers 
for Disease Control and Prevention along with the Infectious Diseases 
Society of America all endorse ASPs as an effective sources to prevent 
the increase and spread of antibiotic resistance [1,6,7]. One of the most 
promising ASP intervention strategies is to decrease the drug resistant 
strains and provide the accurate antibiotics to the ICU patients [8,9]. 
There are several studies evaluate the prospective audit and feedback 
programs have been conducted on wards, cabins and ICUs may be 
the setting with the greatest potential impact [8-10]. All ICU patients 
are prescribed empirical antibiotics which revealed the high levels 
of antibiotic resistance [10,11]. On the other hand, inadequate initial 
antibiotic therapy has been associated with mortality in critically ill 
patients [12]. Still, now, there have been some studies which provide 
the impact of audit and feedback in ICUs [11,13-16].
ICU patients are mostly immunocompromised, and they need specific 
drug during their treatments. ICUs are one of the sources for the 
containment of antibiotic resistance. Nosocomial infections are the 
major cause for cross contamination to seriously ill patients, and it is 
due to the indiscriminate use of combined antibiotics and has resulted 
in highly resistant bacteria pathogens [17]. Infections caused by 
drug-resistant microorganisms have higher morbidity and mortality 
rates and higher costs as compare to antibiotic sensitive bacterial 
infections [18-20]. The prevalence of combination antibiotic resistance 
in microorganism is higher among isolates from patients admitted 
to ICU than that among non-ICU inpatients [21-23]. Gram-negative 
bacteria including Pseudomonas aeruginosa have emerged as key 
reason for nosocomial infections and account for around 30% and 5%, 
respectively, of all bloodstream infections [24,25]. Antibiotic resistance 
surveillance programs have verified an increase in resistance among 
these Gram-negative bacteria [23-26]. Bacterial colonization is often a 
primary step in the pathogenesis of nosocomial infections. Therefore, 
the choice of empirical antibiotic therapy depends, at least partly, on 
the colonization and resistance of the microorganisms. Verities of 
mechanisms may lead to the colonization of hospitalized patients 
with resistant strains [27,28]. The patients, after discharging from the 
hospital can spread the drug-resistant bacteria in the community. These 
resistant strains survive for a long period and performed to develop 
infections with resistant bacteria [29,30]. These studies will be limited 
value for major changes in antibiotic resistance of the microorganisms. 
Few other studies revealed that there were no any drug-resistant 
bacteria after discharge from the hospital [31-33]. Many studies did 
not identify the microorganisms for species label [30-32,34]. According 
to these studies, an observed increase in resistance in Gram-negative 
bacteria may, in fact, have been the result for verities of species of the 
organisms [33]. In this study, we isolate the organism from different 
clinical samples from the ICU patients and identifies with species 
label. After identification, the percentage of sensitive and resistance of 
antibiotics with concerned microorganisms were determined.
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METHODS
In this prospective study and approve from the Institutional Ethics 
Committee. The clinical samples; ascitic fluid, blood, central line tip, 
pleural fluid, pus from liver abscess, sputum, tracheal aspiration, urine 
and wound swabs were collected from the patients of neuro-ICU. All the 
clinical samples were cultured in suitable culture media and incubated 
at 37°C for 18 hrs. For pure culture, individually colonies were streaked 
in an agar plate and then processed (Fig. 1). The bacterial colony 
morphology was noted (Table 1) for further identifications with Gram 
stain and biochemical tests.
All Gram-negative bacteria were identified basing on the biochemical 
results (Table 2), whereas all Gram-negative bacteria were identified 
basing upon the test, catalase, oxidase, and coagulase results. The 
results are compared with the colony morphology of the culture 
result also. In Staphylococcus aureus golden yellow, opaque, circular 
colonies white butyrous consistency were observed on nutrient agar 
whereas, yellow colonies were observed on mannitol salt agar, and 
beta-hemolysis was seen on blood agar. After identification, individual 
bacterial were tested for antibiotic sensitivity pattern with Kirby-Bauer 
method. Then, the sensitive or resistances of the used antibiotics were 
detected by measuring the diameter of inhibitor zone created by the 
antibiotics (Fig. 2). All the organisms were identified basing on the 
previous methods [18-25].
RESULTS
A total number of 794 clinical samples from the neuro-ICU patients 
were cultured on suitable media. It is revealed that among them 371 did 
not grow on the microbiological culture media. Whereas rest samples 
grew in the culture media and showed single colony, double colony, and 
3 or more colonies (Table 3).
There was a t-test compared with the number growth samples and 
number of no growth samples, and it was revealed that there was 
Table 1: Morphology and culture characters of clinically isolated Gram‑negative bacteria along with MTCC strains
Bacterium Agar media Colony morphology
Acinetobacter baumannii Nutrient agar (NA) Colorless smooth raised and pinpoint colonies
MacConkey (MAC) agar Colorless smooth, raised, NLF colonies
Enterobacter aerogenes BA Small, round and pin-point colony
MAC agar LF and mucoid colonies
Escherichia coli NA Flat dry, irregular colonies
MAC agar LF, flat dry pink, irregular colonies
EMB agar Flat dry, irregular colonies, with metallic green color
CLED agar translucent blue colonies
Klebsiella pneumoniae MAC agar LF, pink, mucoid colonies
CLED agar Yellow and mucoid colonies
Proteus vulgaris BA Swarming colonies
CLED agar translucent blue colonies
Pseudomonas aeruginosa NA Large, irregular colonies, with bluish green pigment
MAC agar Pale and yellowish (NLF), translucent without black center
XLD agar Red without black center
NA: Not available, EMB: Eosin methylene blue agar, XLD: Xylose lysine deoxycholate, CLED: Cystine lactose electrolyte deficient medium, LF: Lactose fermenting, 
NLF: Non-lactose fermenting,  BA:  Blood agar
Table 2: Summary of results of biochemical tests of isolated Gram‑negative bacteria
Bacteria Catalase Oxidase Indole MR VP Citrate Urease TSI Nitrate M
A. baumannii + ND − − + + V ND − M
Enterobacter aerogenes + ND − − + + V A/A + M
Escherichia coli + ND + + − − − A/AG + M
Klebsiella oxytoca + ND + − + + + A/AG + NM
Klebsiella pneumoniae + ND − − + + + A/AG + NM
Proteus vulgaris + ND − + − V + K/A H2S + M
Proteus mirabilis + ND + + − V + K/A H2S + M
Pseudomonas aeruginosa + + − − − + + ND + M
+: Positive, −: Negative, V: Variable, MR: Methyl red, VP: Voges‑Proskauer, TSI: Triple sugar iron, A: Acid, K: Alkali, G: Gas, H2S: H2S production, M: Motile, NM: Non-motile, 
ND: Not done
Table 3: Types of colonies from different clinical samples of patients
Sample No growth Single colony Double colony 3 or more colony Total growth Total samples
Ascitic fluid 14 2 0 0 2 16
Blood 122 88 32 34 154 276
Central line tip 1 4 0 0 4 5
ET aspiration 2 2 0 0 2 4
Pleural fluid 0 2 0 0 2 2
Pus from liver abscess 7 1 0 0 1 8
Sputum 5 7 3 9 19 24
Tracheal aspiration 4 2 2 10 14 18
Urine 198 79 105 22 206 404
Wound swab 18 4 3 12 19 37
Mean±SD 37.10±67.44 19.10±34.05 14.50±33.28 8.70±11.59 42.30±73.94 79.40±141.02
Total 371 191 145 87 794
SD: Standard deviation
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Fig. 1: Isolation of single colony with streak plate method
Fig. 2: Antibiotic sensitivity pattern of bacteria by disc diffusion 
methods
no any statistically significantly as p=0.87. Thus, the samples of the 
ICU patients may or may not contain microorganisms for growth as 
it is equally distributed according to t-test. All colonies were tested 
biochemically for the identification of bacteria. It is found that Klebsiella 
pneumonia (230) is the major contaminated bacteria in neuro-ICU. 
Minimum contaminated, i.e., 9 Proteus vulgar were isolated from the 
clinical samples of the neuro-ICU patients (Table 4). The organism 
isolated with different clinical samples were compared with t-test 
with urine sample and revealed significant with abscess fluid (p=0.04), 
pleural fluid (0.02), pus from liver abscess (p=0.04), and with total 
sample (p=0.01) (Tables 5 and 6).
DISCUSSION
This study documents the microorganisms isolated from ICU and 
subsequently found the sensitivity and resistance of antibiotics 
with concerned microorganisms. The prevalence of Gram-negative 
bacteria is found more as compared to the Gram-positive bacteria in 
ICU. Sometimes, patients under treatment with antibiotics revealed 
suppression of growth in culture medium [35]. Hospital practice 
may be the cause for these cases. This hypothesis is supported by the 
fact that the growth of bacteria rates at different times and between 
the two populations were inversely related to use of antibiotic at the 
measured levels. Thus, the higher the level of antibiotics used, the 
lower the bacterial colonization rate. Second, either fresh urine 
specimens or some other samples were collected, and a bias may have 
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low colonization rates of Gram-negative or Gram-positive bacteria in 
hospitalized patients [37-39].
In a study, daily use of antibiotics was reduced 28% in the TNICU 
(1433 vs. 1037) but increased 14% in the MSICU (1705 vs. 1936). The 
total monthly antimicrobial use in the TNICU decreased by 375 DDD per 
1000 patient days (p<0.0009) immediately following the intervention, 
followed by a nonsignificant downward trend in use of - 9 DDD per 
1000 patient days (p=0.56) [40].
A high prevalence of health care-associated infections was observed, 
mainly caused by Gram-negative bacteria with high carbapenem 
resistance rates. This in combination with a high rate of antimicrobial 
use illustrates the urgent need to improve rational antimicrobial use 
and infection control efforts [41-43]. However, from a study, it was 
partially confirmed that ICU patients would be exposed to water 
amoeba-associated microorganisms and provides information about 
the magnitude of AAM infection in ICU patients, especially patients 
that have a prolonged ICU stay. However, the incidence of this exposure 
on the development of pneumonia remains to assess [44]. The use of 
antibiotics and its resistance became significant challenges for patient 
safety as well as management of the critically ill on ICU. ASPs aim to 
optimize appropriate antibiotic treatment while minimizing antibiotic 
resistance. Different models of ASP in ICU, include “standard” control 
of antibiotic prescribing such as “de-escalation strategies” through 
to interventional approaches utilizing biomarker-guided antibiotic 
prescribing. No study has demonstrated a survival benefit of ASP. 
Ongoing challenges to infectious disease management, reported by 
the WHO global report 2014, are high AMR to newer antibiotics, 
and regional knowledge gaps in AMR surveillance. Improved AMR 
surveillance data, identifying core aspects of successful ASPs that are 
transferable and further well-conducted trials will be necessary if ASPs 
are to be an effective platform for delivering desired patient outcomes 
and Safety through best antibiotic policy [45].
CONCLUSIONS
This study resulted the most common sources of infection on admission 
to the ICU. The length of hospital stay in patients with infections is 
longer, likely because of the increased numbers of secondary infections 
in these patients. However, mortality rates were identical in these 
groups of patients. Our results demonstrate the potential for audit and 
feedback to significantly reduce antimicrobial use in ICU settings.
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